Telmito Plus 80/12.5 mg Tablets

Adult dose

In patients whose blood pressure is not adequately controlled by telmisartan alone, take once daily with water regardless of meals. Before switching to this medication with fixed doses of each component, it is recommended to assess the individual components in a titrated manner. When clinically appropriate, it may be considered to switch directly from monotherapy to this combination medication. - Telmisartan/Hydrochlorothiazide combination 40/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40 mg. - Telmisartan/Hydrochlorothiazide combination 80/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80 mg. - Telmisartan/Hydrochlorothiazide combination 80/25 mg may be administered to patients whose blood pressure is not adequately controlled with either telmisartan 80 mg or hydrochlorothiazide 12.5 mg single therapy or combination therapy. Sodium or volume depletion must be corrected prior to the start of this medication. Patients with Renal Impairment No dose adjustment is needed for patients with mild to moderate renal impairment. This medication should not be used in patients with severe renal impairment (creatinine clearance < 30 mL/min). Regular monitoring of kidney function is recommended. Patients with Hepatic Impairment This medication should be administered with caution in patients with mild to moderate hepatic impairment. Do not exceed 40/12.5 mg of this medication per day. It should not be administered to patients with severe hepatic impairment (see usage precautions 2). Thiazide diuretics should be used with caution in patients with liver dysfunction. Elderly No dose adjustments are necessary. Children Safety and efficacy in children under 18 years of age have not been established for this medication.

Child dose

Safety and efficacy in children under 18 years of age have not been established for this medication.

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and must be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to any of its components or those with certain liver or kidney diseases. Caution is advised in elderly patients or those with high potassium levels or impaired liver function, as well as in patients with heart diseases or gastrointestinal disorders. The hydrochlorothiazide component may affect the body's electrolyte balance, potentially causing hypokalemia, hyperkalemia, hyponatremia, and other electrolyte disturbances, so regular blood tests are required. This medication may cause skin reactions that are sensitive to sunlight, so patients should avoid UV exposure and take care of skin protection during treatment. Interactions may occur when taken with other antihypertensives, certain diuretics, lithium, potassium supplements, etc., so consultation with a doctor is essential. Symptoms such as dizziness or drowsiness may occur when driving or operating machinery, so caution is required. Overdose may lead to hypotension, electrolyte imbalance, and dehydration, requiring immediate medical assistance. It is not recommended for children or adolescents under 18 years of age as safety and efficacy have not been established.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual abnormalities, paralysis.

Mild side effects

• Dizziness
• diarrhea
• cough
• bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will safely preserve the medication's effectiveness.

Appearance

Oval tablets consisting of two layers, white and pink, may have pink spots on the white layer.

Package unit

30 tablets (10 tablets/PTP x 3)